Ascensia inks global distro sale with Insulet for blood glucose monitor

Ascensia Diabetes Care has expanded its partnership with Insulet (NSDQ:PODD) to include a global commercial deal.

The two companies inked a world-wide development agreement in June last year to connect Ascensia’s Contour Next One blood glucose monitor with Insulet’s next-gen Omnipod system, Omnipod Dash.

Get the full story at our sister site, Drug Delivery Business News.

The post Ascensia inks global distro sale with Insulet for blood glucose monitor appeared first on MassDevice.

from MassDevice http://ift.tt/2DeeZQ7